Haoyue Hu

No ORCID on file · 6 papers in corpus · active 2025-2026

Study types

  • article 3
  • other 3

Condition tags

  • endometriosis 1
article 2026
·doi:10.6084/m9.figshare.32870966

Additional file 1: Supplementary figures and tables.

article 2026
·doi:10.6084/m9.figshare.32870966.v1

Additional file 1: Supplementary figures and tables.

other 2026
·doi:10.6084/m9.figshare.c.8571011.v1

Abstract Background Pro-EGCG has shown therapeutic promise for endometriosis, yet its immunoregulatory mechanisms remain unclear. Myeloid-derived suppressor cells (MDSCs) are key drivers of disease progression. This study investigates wheth…

other 2026
·doi:10.6084/m9.figshare.c.8571011

Abstract Background Pro-EGCG has shown therapeutic promise for endometriosis, yet its immunoregulatory mechanisms remain unclear. Myeloid-derived suppressor cells (MDSCs) are key drivers of disease progression. This study investigates wheth…

article 2026
Chinese medicine ·doi:10.1186/s13020-026-01451-8

BACKGROUND: Pro-EGCG has shown therapeutic promise for endometriosis, yet its immunoregulatory mechanisms remain unclear. Myeloid-derived suppressor cells (MDSCs) are key drivers of disease progression. This study investigates whether Pro-E…

other 2025
American journal of translational research ·doi:10.62347/AOPY5249

OBJECTIVE: Endometriosis increases ovarian cancer (OC) risk through genetic mutations, chronic inflammation, and hormonal dysregulation, yet the underlying molecular pathways remain underexplored. This study aims to identify endometriosis-a…